BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26221585)

  • 1. Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.
    Van-Dunem JC; Rodrigues LC; Alencar LC; Militão-Albuquerque Mde F; Ximenes RA
    Biomed Res Int; 2015; 2015():275029. PubMed ID: 26221585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
    Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacille Calmette-Guerin disease following Bacille Calmette-Guerin vaccination of an HIV-infected health-care worker.
    Vera JH; Hill SC; Rubinstein L
    Int J STD AIDS; 2012 Jul; 23(7):e1-2. PubMed ID: 22844017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
    Hesseling AC; Schaaf HS; Hanekom WA; Beyers N; Cotton MF; Gie RP; Marais BJ; van Helden P; Warren RM
    Clin Infect Dis; 2003 Nov; 37(9):1226-33. PubMed ID: 14557968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
    Sohail S; Afzal M; Anwar V; Shama Q
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of bloodstream pathogens in a bacille Calmette-Guérin (BCG)-vaccinated pediatric population in Malawi: a pilot study.
    Archibald LK; Nwanyanwu O; Kazembe PN; Mwansambo C; Bell M; Dobbie H; Reller LB; Jarvis WR
    Clin Microbiol Infect; 2003 Mar; 9(3):234-8. PubMed ID: 12667257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.
    Lule SA; Mawa PA; Nkurunungi G; Nampijja M; Kizito D; Akello F; Muhangi L; Elliott AM; Webb EL
    Vaccine; 2015 Feb; 33(6):796-804. PubMed ID: 25529292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review.
    Azzopardi P; Bennett CM; Graham SM; Duke T
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1331-44. PubMed ID: 19861003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial.
    Nemes E; Hesseling AC; Tameris M; Mauff K; Downing K; Mulenga H; Rose P; van der Zalm M; Mbaba S; Van As D; Hanekom WA; Walzl G; Scriba TJ; McShane H; Hatherill M;
    Clin Infect Dis; 2018 Feb; 66(4):554-563. PubMed ID: 29028973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG-itis in two antiretroviral-treated HIV-infected infants.
    de Souza Campos Fernandes RC; Medina-Acosta E
    Int J STD AIDS; 2010 Sep; 21(9):662-3. PubMed ID: 21097744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Bacille Calmette-Guérin infection at a glance: a mini review of the literature.
    Hassanzad M; Valinejadi A; Darougar S; Hashemitari SK; Velayati AA
    Adv Respir Med; 2019; 87(4):239-242. PubMed ID: 31476012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of European badgers (Meles meles) with BCG by the subcutaneous and mucosal routes induces protective immunity against endobronchial challenge with Mycobacterium bovis.
    Corner LA; Costello E; Lesellier S; O'Meara D; Gormley E
    Tuberculosis (Edinb); 2008 Nov; 88(6):601-9. PubMed ID: 18468490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of BCG scar reading among HIV-infected children.
    Van-Dunem JC; de Alencar LC; Rodrigues LC; de Albuquerque Mde F; Ramos ME; Ximenes RA
    Vaccine; 2010 Feb; 28(9):2067-9. PubMed ID: 20060085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A systematic review on the protective efficacy of BCG against children tuberculosis meningitis and millet tuberculosis].
    Xiong CH; Liang XF; Wang HQ
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):358-62. PubMed ID: 20077739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.